SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-040296
Filing Date
2024-05-07
Accepted
2024-05-07 10:21:59
Documents
3
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0205419-6k_neuro.htm 6-K 10389
2 PRESS RELEASE, DATED MAY 7, 2024 ea020541901ex99-1_neuro.htm EX-99.1 24497
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2708
  Complete submission text file 0001213900-24-040296.txt   39827
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 24920177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)